Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-14-000911

Options or other derivatives

  • Director acquired 65,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SAXE JON S Director 2014-03-19 Other acquisition · Warrant +65,000 65,000 D
Loading xslF345X03/form4-03212014_020322.xml…